July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Orbital fibroblasts from thyroid-associated ophthalmopathy patients secret IL-6 via up-regulation of IGF-1 by activating the NF-kB pathway.
Author Affiliations & Notes
  • Sung Eun Kim
    Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Jia Kim
    Department of Pathology, College of Medicine, The Catholic University of Korea, Institute of Hansen's Disease, Seoul, Korea (the Republic of)
  • Ji-Young Lee
    Department of Pathology, College of Medicine, The Catholic University of Korea, Institute of Hansen's Disease, Seoul, Korea (the Republic of)
  • Seong-Beom Lee
    Department of Pathology, College of Medicine, The Catholic University of Korea, Institute of Hansen's Disease, Seoul, Korea (the Republic of)
  • Ji-Sun Paik
    Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • So-Youl Kim
    MyungDong St.Mary's Eye Clinic, Korea (the Republic of)
  • Suk-Woo Yang
    Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Sung Eun Kim, None; Jia Kim, None; Ji-Young Lee, None; Seong-Beom Lee, None; Ji-Sun Paik, None; So-Youl Kim, None; Suk-Woo Yang, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6204. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sung Eun Kim, Jia Kim, Ji-Young Lee, Seong-Beom Lee, Ji-Sun Paik, So-Youl Kim, Suk-Woo Yang; Orbital fibroblasts from thyroid-associated ophthalmopathy patients secret IL-6 via up-regulation of IGF-1 by activating the NF-kB pathway.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6204. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Interleukin (IL)-6 plays as a modulator for functions of lymphocytes. Significantly higher level of IL-6 has been observed in primary orbital tissue cultures of thyroid-associated ophthalmopathy (TAO) patients compared to those of non-TAO patients. In the current study, we investigated the issue of whether of how orbital fibroblasts (OFs) from TAO patients significantly secret higher level of IL-6.

Methods : Human OFs were obtained from orbital fat from decompression surgery in patients with TAO or from upper lid blepharoplasties in patients with no prior history of thyroid disease. The levels of IL-6 and insulin-like growth factor (IGF)-1 in culture media of OFs were determined by using an ELISA kit. The NF-kB activity of OFs was determined by measuring the level of IkB degradation and IKKa/ IKKb/NF-kBp65 phosphorylation.

Results : Cultured OFs from TAO patients significantly secreted higher level of IL-6 and IGF-1, compared with those of control groups (P<0.05). In addition, treatment with IGF-1 induced secretion of IL-6 in OFs from TAO patients. The levels of IkB degradation and IKKa/IKKb/NF-kBp65 phosphorylation were higher in non-treated OFs of TAO patients than those of control groups. Furthermore, treatment with Bay 11-7082, an inhibitor of NF-kB pathway, reduced the secretion of IL-6 and IGF-1 in OFs from TAO patients.

Conclusions : These results suggest that IL-6 secretion is dependent on NF-kB/IGF-1 pathway in OFs from TAO patients. These findings also show that NF-kB/IGF-1/IL-6 pathway may be a reasonable target of therapeutic intervention in the case of TAO.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×